Nakao Y, Matsumoto H, Okubo A, Miyazaki T, Iwasaki Y, Okimoto K, Yoshiba A, Kumada H, Fujita T
Clin Exp Immunol. 1983 Jun;52(3):493-8.
We studied Gm typing of serum samples from 838 donors; 177 had chronic hepatitis, 166 liver cirrhosis, 113 primary hepatocellular carcinoma, 21 alcoholic hepatitis, 18 fatty liver and 343 were unrelated normal blood donors. The distribution of Gm phenotypes and haplotypes in sera from patients with primary hepatocellular carcinoma differed from that in the normal controls; the Gm phenotype (1,2,21,13,15,16) and the haplotype Gm1,2,21 were significantly more common in this patient group (X2 = 18.56, corrected P less than 0.01, relative risk = 3.12; X2 = 25.52, corrected P less than 0.005, respectively). Overall, in the other liver diseases, we observed no significant Gm phenotype or haplotype association. The commitment to progression to primary liver carcinoma seems to be ascribable to a gene or polygenes close to the IgG heavy chain loci.
我们研究了838名献血者血清样本的Gm分型;其中177人患有慢性肝炎,166人患有肝硬化,113人患有原发性肝细胞癌,21人患有酒精性肝炎,18人患有脂肪肝,343人为非相关正常献血者。原发性肝细胞癌患者血清中Gm表型和单倍型的分布与正常对照组不同;Gm表型(1,2,21,13,15,16)和单倍型Gm1,2,21在该患者组中显著更常见(X2 = 18.56,校正P小于0.01,相对风险 = 3.12;X2 = 25.52,校正P分别小于0.005)。总体而言,在其他肝脏疾病中,我们未观察到显著的Gm表型或单倍型关联。进展为原发性肝癌的倾向似乎归因于靠近IgG重链基因座的一个基因或多个基因。